News | December 23, 2025
Zydus Partners with Bioeq for US commercialisation rights for Nufymco
NUFYMCO BLA has been approved by the USFDA
NUFYMCO BLA has been approved by the USFDA
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Poviztra is a second brand of Wegovy
The facility has been designed with a dual focus on efficiency and sustainability
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Subscribe To Our Newsletter & Stay Updated
